---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-085182"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2022-08-02T23:59:59+00:00"
generated_at: "2026-06-24T05:49:41.646520+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences appoints Paul F. Hickey as CEO, effective Aug 15, 2022

## Summary
- Paul F. Hickey appointed President and CEO, succeeds Bart Bandy who departed to pursue other opportunities.
- CFO Thomas Stankovich serves as interim CEO until Hickey joins; Dan Gladney becomes Executive Chair.
- Hickey receives $400K base salary, bonus up to 50% of salary, and stock option grant of 4% fully diluted shares.
- Stankovich receives retention bonus of 100% target 2022 cash bonus if employed through Dec 31, 2022.
- Hickey previously SVP Marketing at EnteroMedics (predecessor ReShape) and CEO at Altimate Medical.

## SEC filing metadata
- accession: 0001104659-22-085182
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2022-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/tm2222383d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-085182
- JSON: https://secwatch.observer/filing/0001104659-22-085182.json
- Plain text: https://secwatch.observer/filing/0001104659-22-085182.txt

## Key facts
- Executive change
  Bart Bandy resigned as Member of the Board of Directors at Vyome Holdings, Inc.
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: Mr. Bandy also resigned from the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- Executive change
  Paul F. Hickey was appointed as Member of the Board of Directors at Vyome Holdings, Inc.
  - Action: appointed
  - Role: Member of the Board of Directors
  source text: On July 27, 2022, ReShape Lifesciences Inc. (the “Company”) announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- Executive change
  Bart Bandy departed as President and Chief Executive Officer at Vyome Holdings, Inc.
  - Action: separated
  - Role: President and Chief Executive Officer
  source text: Mr. Hickey succeeds Bart Bandy, who has separated from the Company to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- Executive change
  Paul F. Hickey was appointed as President and Chief Executive Officer at Vyome Holdings, Inc.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On July 27, 2022, ReShape Lifesciences Inc. (the “Company”) announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- Executive change
  Thomas Stankovich was appointed as Interim President and Chief Executive Officer at Vyome Holdings, Inc.
  - Action: appointed
  - Role: Interim President and Chief Executive Officer
  source text: Thomas Stankovich, Chief Financial Officer of the Company, will serve as Interim President and Chief Executive Officer until Mr. Hickey joins the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm
- Executive change
  Dan W. Gladney was appointed as Executive Chair at Vyome Holdings, Inc.
  - Action: appointed
  - Role: Executive Chair
  source text: Dan W. Gladney, current Chair of the Board of Directors, will assume a more active role as Executive Chair, supporting Mr. Hickey and the Company on strategic matters
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000110465922085182/0001104659-22-085182-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.